In this episode of Huberman Lab Essentials, my guest is Dr. Karl Deisseroth, M.D., Ph.D., a clinical psychiatrist and professor of bioengineering and of psychiatry and behavioral sciences at Stanford University.We discuss his experiences as a clinician treating complex psychiatric conditions and his lab’s pioneering work in developing transformative therapies for mental illness. He explains the complexities of mental illness and how emerging technologies—such as optogenetics and brain-machine interfaces—could revolutionize care. We also explore promising new therapies, including psychedelics and MDMA, for conditions like depression and PTSD.Read the episode show notes at hubermanlab.com.Huberman Lab Essentials are short episodes focused on essential science and protocol takeaways from past full-length Huberman Lab episodes. Watch or listen to the full-length episode at ⁠hubermanlab.com⁠.Thank you to our sponsorsAG1: https://drinkag1.com/hubermanDavid: https://davidprotein.com/hubermanEight Sleep: https://eightsleep.com/hubermanTimestamps00:00:00 Karl Deisseroth; Neurology vs Psychiatry00:01:36 Speech; Blood Test?; Seeking Help00:04:20 Feelings, Jargon; Psychiatric Treatment00:09:40 Sponsor: David00:10:55 Future Treatment; Vagus Nerve Stimulation, Depression, Optogenetics00:19:40 Brain-Machine Interfaces00:20:53 Sponsor: Eight Sleep00:23:00 ADHD Symptoms, Lifestyle, Technology00:29:34 Psychedelics, Depression Treatment, Risks00:35:43 Sponsor: AG100:37:30 MDMA (Ecstasy), Trauma & Post-Traumatic Stress Disorder (PTSD) Treatment00:40:33 Projections: A Story of Human Emotions Book, OptimismDisclaimer & DisclosuresLearn more about your ad choices. Visit megaphone.fm/adchoices